Incorporating Parp-inhibitors in Primary and Recurrent Ovarian Cancer: A Meta-analysis of 12 phase II/III randomized controlled trials
Ruscito, Ilary, Bellati, Filippo, Ray-Coquard, Isabelle, Mirza, Mansoor Raza, du Bois, Andreas, Gasparri, Maria Luisa, Costanzi, Flavia, De Marco, Maria Paola, Nuti, Marianna, Caserta, Donatella, PignVolume:
87
Journal:
Cancer Treatment Reviews
DOI:
10.1016/j.ctrv.2020.102040
Date:
July, 2020
File:
PDF, 1.00 MB
2020